Anavex Life Sciences Corp (AVXL)

[Gator328]

So we are basically saying the same thing worded differently. I agree that right now Anavex is not an investment-grade security. It has zero revenue and zero salable products. Fund managers aren't looking for home runs; they're looking for singles and doubles and every now and then they'll strike out or hit a home run. If Anavex goes up to $1249 there isn't a single fund manager who loses his or her job over not buying it; if it goes to 0 there may be an exit interview in that manager's future.

Anavex's potential rests with FDA approval and health insurance companies providing coverage or reimbursement. More than likely the federal government will get involved too since most elderly people are on Medicare. When these hurdles are cleared, we'll see a massive flow of shares from retail to institutions and that will provide the price surge we're all waiting for.

Whether the cabal exists or not is irrelevant. Either the drug works or it doesn't, and if it does no amount of message board posting will scare off fund managers from placing large buy orders. I wouldn't want to be short in this scenario.

As for the delay, I don't believe it's due to bad news as some here are speculating. Dr. Missling isn't attending these investor conferences to serve the investment community a giant sh*t sandwich. There are just too many other actions that make me believe he's pushing forward on all fronts. The silence is intentional, and it's probably because he's learned that it's best to remain silent at this point and let a journal or the FDA speak on his behalf at some point in the future.